Biomarkers In Early Clinical Trials: the Committed and the Skeptics
Open Access
- 15 April 2008
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 14 (8), 2512
- https://doi.org/10.1158/1078-0432.ccr-07-5224
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Trends in the Use and Role of Biomarkers in Phase I Oncology TrialsClinical Cancer Research, 2007
- Biomarkers in Phase I Oncology Trials: Signal, Noise, or Expensive Distraction?Clinical Cancer Research, 2007
- First in human phase I pharmacokinetic (PK) and pharmacodynamic (PD) study of KU-0059436 (Ku), a small molecule inhibitor of poly ADP-ribose polymerase (PARP) in cancer patients (p), including BRCA1/2 mutation carriersJournal of Clinical Oncology, 2007
- Economics of New Oncology Drug DevelopmentJournal of Clinical Oncology, 2007
- Pharmacodynamic Biomarkers for Molecular Cancer TherapeuticsAdvances in Cancer Research, 2006
- Phase I Pharmacokinetic and Pharmacodynamic Study of 17-Allylamino, 17-Demethoxygeldanamycin in Patients With Advanced MalignanciesJournal of Clinical Oncology, 2005